Dearry A, Gingrich JA, Falardeau P, Fremeau RT, Bates MD, Caron MG (September 1990). „Molecular cloning and expression of the gene for a human D1 dopamine receptor”. Nature347 (6288): 72–6. DOI:10.1038/347072a0. PMID2144334.
Zhou QY, Grandy DK, Thambi L, Kushner JA, Van Tol HH, Cone R, Pribnow D, Salon J, Bunzow JR, Civelli O (September 1990). „Cloning and expression of human and rat D1dopamine receptors”. Nature347 (6288): 76–80. DOI:10.1038/347076a0. PMID2168520.
Sunahara RK, Niznik HB, Weiner DM, Stormann TM, Brann MR, Kennedy JL, Gelernter JE, Rozmahel R, Yang YL, Israel Y, O'Dowd BF. (September 1990). „Human dopamine D1 receptor encoded by an intronless gene on chromosome 5”. Nature347 (6288): 80–3. DOI:10.1038/347080a0. PMID1975640.
Zhang J, Xiong B, Zhen X, Zhang A. (2009). „Dopamine D1 receptor ligands: where are we now and where are we going.”. Med Res Rev.29 (2): 272–294. DOI:10.1002/med.20130. PMID18642350.
Cueva JP, Giorgioni G, Grubbs RA, Chemel BR, Watts VJ, Nichols DE (November 2006). „trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist”. J. Med. Chem.49 (23): 6848–57. DOI:10.1021/jm0604979. PMID17154515.
Michaelides MR, Hong Y, DiDomenico S, Asin KE, Britton DR, Lin CW, Williams M, Shiosaki K (1995). „(5aR,11bS)-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-azacyclopent-1- ena[c]-phenanthrene-9,10-diol (A-86929): a potent and selective dopamine D1agonist that maintains behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431)”. J. Med. Chem.38 (18): 3445–7. DOI:10.1021/jm00018a002. PMID7658429.
Yamashita M, Yamada K, Tomioka K (2004). „Construction of arene-fused-piperidine motifs by asymmetric addition of 2-trityloxymethylaryllithiums to nitroalkenes: the asymmetric synthesis of a dopamine D1 full agonist, A-86929”. J. Am. Chem. Soc.126 (7): 1954–5. DOI:10.1021/ja031760n. PMID14971926.
Bermak, Jason C; Li Ming, Bullock Clayton, Weingarten Paul, Zhou Qun-Yong (February 2002). „Interaction of gamma-COP with a transport motif in the D1 receptor C-terminus”. Eur. J. Cell Biol. (Germany) 81 (2): 77–85. DOI:10.1078/0171-9335-00222. ISSN0171-9335. PMID11893085.
Bermak, J C; Li M, Bullock C, Zhou Q Y (May 2001). „Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein”. Nat. Cell Biol. (England) 3 (5): 492–8. DOI:10.1038/35074561. ISSN1465-7392. PMID11331877.
Dearry A, Gingrich JA, Falardeau P, Fremeau RT, Bates MD, Caron MG (September 1990). „Molecular cloning and expression of the gene for a human D1 dopamine receptor”. Nature347 (6288): 72–6. DOI:10.1038/347072a0. PMID2144334.
Zhou QY, Grandy DK, Thambi L, Kushner JA, Van Tol HH, Cone R, Pribnow D, Salon J, Bunzow JR, Civelli O (September 1990). „Cloning and expression of human and rat D1dopamine receptors”. Nature347 (6288): 76–80. DOI:10.1038/347076a0. PMID2168520.
Sunahara RK, Niznik HB, Weiner DM, Stormann TM, Brann MR, Kennedy JL, Gelernter JE, Rozmahel R, Yang YL, Israel Y, O'Dowd BF. (September 1990). „Human dopamine D1 receptor encoded by an intronless gene on chromosome 5”. Nature347 (6288): 80–3. DOI:10.1038/347080a0. PMID1975640.
Zhang J, Xiong B, Zhen X, Zhang A. (2009). „Dopamine D1 receptor ligands: where are we now and where are we going.”. Med Res Rev.29 (2): 272–294. DOI:10.1002/med.20130. PMID18642350.
Cueva JP, Giorgioni G, Grubbs RA, Chemel BR, Watts VJ, Nichols DE (November 2006). „trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist”. J. Med. Chem.49 (23): 6848–57. DOI:10.1021/jm0604979. PMID17154515.
Michaelides MR, Hong Y, DiDomenico S, Asin KE, Britton DR, Lin CW, Williams M, Shiosaki K (1995). „(5aR,11bS)-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-azacyclopent-1- ena[c]-phenanthrene-9,10-diol (A-86929): a potent and selective dopamine D1agonist that maintains behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431)”. J. Med. Chem.38 (18): 3445–7. DOI:10.1021/jm00018a002. PMID7658429.
Yamashita M, Yamada K, Tomioka K (2004). „Construction of arene-fused-piperidine motifs by asymmetric addition of 2-trityloxymethylaryllithiums to nitroalkenes: the asymmetric synthesis of a dopamine D1 full agonist, A-86929”. J. Am. Chem. Soc.126 (7): 1954–5. DOI:10.1021/ja031760n. PMID14971926.
Bermak, Jason C; Li Ming, Bullock Clayton, Weingarten Paul, Zhou Qun-Yong (February 2002). „Interaction of gamma-COP with a transport motif in the D1 receptor C-terminus”. Eur. J. Cell Biol. (Germany) 81 (2): 77–85. DOI:10.1078/0171-9335-00222. ISSN0171-9335. PMID11893085.
Bermak, J C; Li M, Bullock C, Zhou Q Y (May 2001). „Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein”. Nat. Cell Biol. (England) 3 (5): 492–8. DOI:10.1038/35074561. ISSN1465-7392. PMID11331877.
worldcat.org
Bermak, Jason C; Li Ming, Bullock Clayton, Weingarten Paul, Zhou Qun-Yong (February 2002). „Interaction of gamma-COP with a transport motif in the D1 receptor C-terminus”. Eur. J. Cell Biol. (Germany) 81 (2): 77–85. DOI:10.1078/0171-9335-00222. ISSN0171-9335. PMID11893085.
Bermak, J C; Li M, Bullock C, Zhou Q Y (May 2001). „Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein”. Nat. Cell Biol. (England) 3 (5): 492–8. DOI:10.1038/35074561. ISSN1465-7392. PMID11331877.